A pre-clinical study has shown that low dose insulin administered through the nose can improve movement and help protect dopaminergic neurons from damage.
The SURE-PD trial has indicated inosine was effective at increasing urate levels and slowing disease progression in women, but not men.
AUDIO VERSION AVAILABLE.
Evidence from preclinical studies supports case for a clinical trial of cysteamine in PwP
Patient narratives shown to be used as marketing tool
New surgery may offer relief for gait
Understanding the GDNF trial – BBC2 – 28th Feb & 7th March 2019